Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
about
Eosinophils in Autoimmune Diseases.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Macrophage Subset Expressing CD169 in Peritoneal Cavity-Regulated Mucosal Inflammation Together with Lower Levels of CCL22.Role of MiRNAs in Inflammatory Bowel Disease.Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative ColitisArthritis is developed in Borrelia-primed and -infected mice deficient of interleukin-17.Effects of the Sijunzi decoction on the immunological function in rats with dextran sulfate-induced ulcerative colitis.A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model.Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice.Probiotic Mixture Protects Dextran Sulfate Sodium-Induced Colitis by Altering Tight Junction Protein Expressions and Increasing Tregs.Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitisEffect of Milk Fermented with on the Inflammatory Response in MiceAspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer
P2860
Q33607031-6F86470F-521D-4EB6-BCB7-85E497AAC9C0Q38794312-4C5B1ADA-3F32-40F5-B8C9-2755974D839FQ38807625-4D938FE8-41C5-4B11-A853-DB4500B2C991Q39229393-B0EB72DE-CF28-4FA8-9F3C-9599B0A40D7DQ39424570-644AB1F5-E445-424F-B0B2-B76638ED0757Q40587751-22FEB850-44F7-43AC-8BA1-9AA088753ABBQ41847686-496EF162-D644-4A2D-A671-7BCB707EAABCQ50300727-EC5E4265-C527-48AE-8045-CA356BCAA583Q53695267-1F1FE8AE-BC84-47EA-ABD8-824351F157B3Q54958235-4A49DA6B-3CDC-4A0F-8D62-490AB25E40E8Q57815111-310734A4-B519-4ED9-8370-F84FC50F0417Q58327062-E955A2A7-2B33-4D15-9382-1939C3EC8ED7Q58777471-385A924F-C4EC-401D-A83A-D0403BF5089A
P2860
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@ast
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@en
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@nl
type
label
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@ast
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@en
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@nl
prefLabel
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@ast
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@en
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@nl
P2093
P2860
P921
P356
P1476
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
@en
P2093
Beatrice Mugendi
Eddy Owaga
Jung-Su Chang
Rong-Hong Hsieh
Sakhile Masuku
P2860
P304
20841-20858
P356
10.3390/IJMS160920841
P407
P5008
P577
2015-09-01T00:00:00Z